Login / Signup

TAS-102, Irinotecan, and bevacizumab in pre-treated metastatic colorectal cancer (TABAsCO), a phase II clinical trial.

Patrick M BolandSarbajit MukherjeeIman ImaniradNamrata VijayvergiaSeth D CohenMedhavi GuptaRenuka V IyerAndrei BakinJianxin WangSarah ChatleyBeth CahillDeepak VadehraKristopher AttwoodHoward S HochsterChristos Fountzilas
Published in: British journal of cancer (2024)
ClinicalTrials.gov NCT04109924.
Keyphrases
  • metastatic colorectal cancer
  • phase ii
  • clinical trial
  • open label
  • double blind
  • phase iii
  • placebo controlled
  • study protocol
  • randomized controlled trial